US EditionEliminating Hepatitis C in Europe: A Report on Policy Implementation for People Who Inject Drugs. Civil Society Monitoring of Harm Reduction in Europe 2024 – European Harm Reduction Network
Summary by Correlation-net.org
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Eliminating Hepatitis C in Europe: A Report on Policy Implementation for People Who Inject Drugs. Civil Society Monitoring of Harm Reduction in Europe 2024 – European Harm Reduction Network
The Hepatitis C Virus (HCV) poses a serious public health challenge across Europe, especially in urban areas where vulnerable groups are most affected. Chronic hepatitis from hepatitis B (HBV) and HCV infections remains a leading risk factor for liver cancer, Europe’s sixth most common cause of cancer-related deaths, with nearly 55,000 fatalities in 2022 (ECDC 2024)(1). This report draws on a survey from harm reduction services in 40 European ci…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
